Tactical Therapeutics Overview

  • Founded
  • 2005

Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $50M

Tactical Therapeutics General Information

Description

Developer of a clinical-stage therapeutic drug company designed to develop an inhibitor of non-voltage calcium signaling and channels to treat glioblastoma and other drug-resistant solid cancers. The company's drugs include therapeutic carboxyamidotriazole orotate for the orphan indication glioblastoma and for other refractory targets, its products modulate multiple signaling pathways and work in combination with traditional chemotherapy and targeted drugs to achieve clinical efficacy, enabling resistance and recurrence of tumors and helping physicians to overcome resistance in malignant brain cancer.

Contact Information

Website
www.tacticaltherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 48 Wall Street
  • 12th Floor
  • New York, NY 10005
  • United States
+1 (917) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tactical Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 03-Sep-2021 $50M 0000 00000 In Progress Clinical Trials - Phase 2
1. Angel (individual) 0000 0000 00000 Completed Startup
To view Tactical Therapeutics’s complete valuation and funding history, request access »

Tactical Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical-stage therapeutic drug company designed to develop an inhibitor of non-voltage calcium signaling
Drug Discovery
New York, NY
1 As of 2022
0000
0000 0000-00-00
00000000000 0000

000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
0000 000000000
Buffalo, NY
0 As of 0000
0000
0000000000 0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tactical Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Venture Capital-Backed Buffalo, NY 0 0000 0000000000 0 0000
You’re viewing 1 of 1 competitors. Get the full list »

Tactical Therapeutics Patents

  • 68

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Tactical Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11318118-B1 Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate Active 05-Apr-2021 00000000000 0
AU-2021322599-A1 Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate Pending 05-Aug-2020 000000000
CA-3185943-A1 Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate Pending 05-Aug-2020 000000000
EP-4192452-A1 Methods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate Pending 05-Aug-2020 000000000
US-20220168276-A1 Mehods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate Inactive 05-Aug-2020 A61P31/12
To view Tactical Therapeutics’s complete patent history, request access »

Tactical Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Rashida Karmali Ph.D Founder, Co-Chief Executive Officer, President, Chairman, Part-Time Chief Financial Officer & Chief Medical Officer
To view Tactical Therapeutics’s complete executive team members history, request access »

Tactical Therapeutics Board Members (2)

Name Representing Role Since
Rashida Karmali Ph.D Tactical Therapeutics Founder, Co-Chief Executive Officer, President, Chairman, Part-Time Chief Financial Officer & Chief Medical Officer 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Tactical Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial